Login to Your Account

Government Funding as a Business Model: Win-Win, Mostly

By Donna Young

Monday, April 6, 2009
Given the current economic markets and difficulties in raising equity, government contracts or grants can be important sources of nondilutive funds for biotechnology companies, said Karl Handelsman, managing director of San Francisco-based venture capital firm CMEA Capital.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription